One Financial Institution currently invests or makes available an estimated

USD$ 28 million in nuclear weapons companies.

Allied Irish Banks

Allied Irish Banks currently has an estimated USD$ 28.00 million invested or available for the nuclear weapons producers identified in this report.


In May 2010, Babcock & Wilcox Investment Company, a subsidiary of Babcock & Wilcox, secured a four-year revolving credit facility with a value of US$ 700 million. The proceeds were used for working capital, capital expenditure, refinancing and general corporate purposes. Allied Irish Investment Bank, a subsidiary of Allied Irish Banks, was part of the 17 bank syndicate, committing an estimated amount of US$ 28 million.(( Bloomberg Database, “Loan finder”, Bloomberg Database, viewed July 2013; Thomson ONE Banker, “Tearsheet 2582202115”, Thomson ONE Banker (, 30 April 2010; Babcock & Wilcox, “Credit Agreement dated as of May 3, 2010”, Babcock & Wilcox, 3 May 2010; Babcock & Wilcox, “Annual Report 10K”, Babcock & Wilcox, March 2011 (


This page contains country specific information from the 2013 Don’t Bank on the Bomb report. It identifies which financial institutions have significant financing relationships with one or more of the 27 nuclear weapons producers.

The financial institutions identified include banks, pension funds, sovereign wealth funds, insurance companies and asset managers. They have provided various types of financial services to nuclear weapon companies. The most important are loans, investment banking and asset management.

All sources of financing provided since 1 January 2010 to the companies listed were analysed from annual reports, financial databases and other sources. The financial institutions which are most significantly involved in the financing of one or more nuclear weapon companies are shown here. See the full report for both a summary and full description of all financial institutions which are found to have the most significant financing relationships with one or more of the selected nuclear weapon companies, by means of participating in bank loans, by underwriting share or bond issues and/or by share- or bondholdings (above a threshold of 0.5% of all outstanding shares or bonds).